跳到正文
Hidehito HORINOUCHI· @HHorinouchi · X·· 19 小时前评分45

#LCSM

正文 · 原文

🆙#ESMO26 #LCSM Special Symposium
🔥SCLC: Can we finally tackle it?
🎯Emerging targets for SCLC: Are molecular classification and treatment selection going to help? (Incl. neversmorkers)
🎙️ @charlesrudin
🔗 https://cslide.ctimeetingtech.com/esmo2026/attendee/confcal/show/session/29
@OncoAlert @Larvol @myESMO

167 浏览 · 5 赞 · 4 转发 · 0 回复

来源:Hidehito HORINOUCHI · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org